Related Experiment Videos

Calcium antagonist receptors in cardiomyopathic hamster: selective increases in heart, muscle, brain

Science (New York, N.Y.)
|April 25, 1986
PubMed

Insights

Syrian cardiomyopathic hamsters exhibit hereditary myocardial necrosis, a condition linked to calcium overload. This cardiac disease, treatable with verapamil, shows increased calcium antagonist receptors and brain synaptosome uptake, suggesting a role in pathogenesis.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Syrian cardiomyopathic hamsters possess a hereditary condition characterized by progressive myocardial necrosis.
  • This condition shares similarities with human cardiac hypertrophy and is associated with cellular calcium overload.
  • The calcium antagonist verapamil has demonstrated preventative effects on the observed lesions.

Purpose of the Study:

  • To investigate the role of calcium channels and calcium antagonist receptors in the pathogenesis of cardiomyopathy in Syrian hamsters.
  • To explore the relationship between calcium overload and the observed myocardial necrosis.

Main Methods:

  • Quantification of calcium antagonist receptor binding sites in various tissues (heart, brain, skeletal muscle, smooth muscle) of cardiomyopathic hamsters compared to controls.
  • Measurement of calcium-45 uptake into brain synaptosomes in cardiomyopathic hamsters.

Main Results:

  • Markedly increased numbers of calcium antagonist receptor binding sites were observed in the heart, brain, skeletal muscle, and smooth muscle of cardiomyopathic hamsters.
  • Enhanced uptake of calcium-45 into brain synaptosomes was noted in these hamsters.
  • These findings suggest alterations in calcium regulation and receptor expression.

Conclusions:

  • The increased prevalence of calcium antagonist receptors and associated voltage-sensitive calcium channels may play a significant role in the development of this cardiomyopathy.
  • Understanding these mechanisms could offer insights into human cardiac hypertrophy and related calcium channelopathies.

Related Concept Videos